COVID-19 Induces Greater NLRP3 Inflammasome Activation in Obese Patients than Other Chronic Illnesses: A Case–Control Study
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26041541 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Raíssa Campos D'Amico und 9 weiteren Autor:innen. Beteiligte Einrichtung: Post-Graduate Program in Health Sciences (PPGCS), Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, Paraná, Brazil. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, COVID-19, Obesity, Inflammasomes. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Banco Regional de Desenvolvimento do Extremo Sul, CNPq, BRDE-PUCPR.
Abstract (Originalsprache)
Obesity has been identified as an independent risk factor for severe COVID-19 unfavorable outcomes. Several factors, such as increased ACE2 receptor expression and chronic inflammation, can contribute to this relationship, yet the activation of the NLRP3 inflammasome pathway is also a key element. Our primary goal was to determine whether chronic NLRP3 inflammasome activation in people with obesity is different in critical COVID-19 and in critical chronic conditions. A retrospective analysis was conducted using clinical data and post-mortem lung tissue samples from 14 COVID-19 patients with obesity (group A) and 9 patients with obesity who died from non-COVID-19 causes (group B). Immunohistochemical analysis assessed twelve markers related to the NLRP3 inflammasome pathway. Group A showed a significantly higher expression of ASC (p = 0.0387) and CASP-1 (p = 0.0142). No significant differences were found for IL-8, TNF-α, NF-kB, NLRP3, IL-1β, and gasdermin-D. Group B had higher levels of IL-6 (p < 0.0001), IL-18 (p = 0.002), CASP-9 (p < 0.0001), and HIF (p = 0.0327). We concluded that COVID-19 activates the NLRP3 inflammasome pathway, possibly leading to pyroptotic cell death mediated by caspase-1. In contrast, people with obesity without COVID-19, despite exhibiting some markers of the NLRP3 inflammasome, are more likely to experience necroptosis mediated by caspase-9.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Post-Graduate Program in Health Sciences (PPGCS), Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, Paraná, Brazil.
- School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, Paraná, Brazil.
- School of Medicine, Universidade Federal do Paraná, Curitiba 80060-240, Paraná, Brazil.
ORCID-Profile: Raíssa Campos D'Amico, Seigo Nagashima, Lucas Baena Carstens, Sabrina Mataruco, Júlio Cesar Honório D'Agostini, Cristina Pellegrino Baena
Förderung
- Banco Regional de Desenvolvimento do Extremo Sul
- CNPq
- BRDE-PUCPR
Zitieren
APA
D'Amico, R. C., Nagashima, S., Carstens, L. B., Bertoldi, K. G., Mataruco, S., Honório D'Agostini, J. C., Hlatchuk, E. C., da Silva, S. B., de Noronha, L., & Baena, C. P. (2025). COVID-19 Induces Greater NLRP3 Inflammasome Activation in Obese Patients than Other Chronic Illnesses: A Case–Control Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041541
Vancouver
D'Amico RC, Nagashima S, Carstens LB, Bertoldi KG, Mataruco S, Honório D'Agostini JC, et al. COVID-19 Induces Greater NLRP3 Inflammasome Activation in Obese Patients than Other Chronic Illnesses: A Case–Control Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041541
BibTeX
@article{DAmico2025,
author = {D'Amico, Raíssa Campos and Nagashima, Seigo and Carstens, Lucas Baena and Bertoldi, Karina de Guadalupe and Mataruco, Sabrina and Honório D'Agostini, Júlio Cesar and Hlatchuk, Elisa Carolina and da Silva, Sofia Brunoro and de Noronha, Lucia and Baena, Cristina Pellegrino},
title = {COVID-19 Induces Greater NLRP3 Inflammasome Activation in Obese Patients than Other Chronic Illnesses: A Case–Control Study},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26041541}
}
EUVIMED